Real-World Adherence and Drug Survival of Biologics among Patients with Ankylosing Spondylitis.

J Clin Med · 2024 · PMC11313093 · PMID 39124747

Europe PMC DOI

hedged sentence

0.9400

closest p · 18.8× alpha

0.9400

boldest claim

The sentences

did not reach statistical significancep = 0.94not close (p > 0.1)

Among the biologic-experienced group, after 12 months, GOL and SEC displayed similar drug survival rates, followed by ADA and ETN; however, the results did not reach statistical significance ( p = 0.94).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.